Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
15.14
+0.04 (0.26%)
At close: Feb 13, 2026, 4:00 PM EST
15.16
+0.02 (0.13%)
After-hours: Feb 13, 2026, 7:27 PM EST
TNXP Market Cap
TNXP has a market cap or net worth of $193.7 million as of February 13, 2026. Its market cap has increased by 176.38% in one year.
Market Cap
193.70M
Enterprise Value
4.07M
1-Year Change
176.38%
Ranking
Category
Stock Price
$15.14
Market Cap Chart
Since July 16, 2019, TNXP's market cap has increased from $7.29M to $193.70M, an increase of 2,555.73%. That is a compound annual growth rate of 64.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 193.70M | 0.07% |
| Dec 31, 2025 | 193.56M | 214.02% |
| Dec 31, 2024 | 61.64M | 160.94% |
| Dec 29, 2023 | 23.62M | 5.35% |
| Dec 30, 2022 | 22.42M | -87.36% |
| Dec 31, 2021 | 177.42M | 37.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcturus Therapeutics Holdings | 204.87M |
| Alector | 204.11M |
| Camp4 Therapeutics | 199.74M |
| NeOnc Technologies Holdings | 199.42M |
| Humacyte | 194.93M |
| Voyager Therapeutics | 188.48M |
| Sol-Gel Technologies | 187.20M |
| Ovid Therapeutics | 184.86M |